Introduction

Acute appendicitis remains the most common surgical emergency worldwide, affecting approximately 7-8% of the population during their lifetime. Despite its frequency, accurate clinical diagnosis continues to challenge physicians, particularly in settings where advanced imaging is not readily available. The diagnostic dilemma arises because the classic presentation of periumbilical pain migrating to the right iliac fossa, accompanied by fever, anorexia, and leukocytosis, occurs in only about 50-60% of patients. Atypical presentations are common in women of reproductive age, the elderly, young children, obese patients, and pregnant women.

Clinical scoring systems have been developed to standardize the diagnostic approach and reduce both unnecessary (negative) appendectomies and delayed diagnoses that lead to perforation and its associated morbidity. While the Alvarado score (1986) has been the most widely used tool for decades, studies in Asian and Middle Eastern populations revealed that it performed suboptimally in these demographics, with sensitivity rates as low as 59-72%. This gap motivated the development of the RIPASA (Raja Isteri Pengiran Anak Saleha Appendicitis) score, a 15-parameter clinical scoring system specifically designed and validated for populations in South and Southeast Asia and the Middle East.

Published in 2010 by Chong and colleagues at the RIPAS Hospital in Brunei Darussalam, the RIPASA score incorporates demographic factors, clinical symptoms, physical examination findings, laboratory investigations, and a unique additional criterion. At a diagnostic cut-off of 7.5, the RIPASA score achieves a sensitivity of 98%, a specificity of 81.3%, a positive predictive value (PPV) of 85.3%, and a negative predictive value (NPV) of 97.4% in its derivation population, outperforming the Alvarado score across all metrics in the same cohort.

Historical Background and Development

The RIPASA score was developed through a prospective study conducted at the Raja Isteri Pengiran Anak Saleha (RIPAS) Hospital in Brunei Darussalam. The investigators recognized that existing appendicitis scoring systems, predominantly the Alvarado score, had been derived and validated in Western populations. These tools assigned weights to parameters based on the clinical presentation patterns observed in those demographics, which did not necessarily translate to populations with different disease prevalence, body habitus, pain perception norms, and healthcare-seeking behavior.

The development process involved analyzing 312 patients who presented with right iliac fossa pain between 2006 and 2008. Through multivariate analysis of clinical, demographic, and laboratory parameters, the investigators identified 15 variables that independently contributed to the diagnosis of acute appendicitis. Each variable was assigned a weighted score based on its discriminatory power, and the total possible score ranges from a minimum of 1.5 to a maximum of 16.0 points.

The score was named after the hospital where it was developed, itself named after the Queen of Brunei, making RIPASA both an institutional and geographic identifier. Since its publication, the RIPASA score has been validated in multiple countries including India, Iran, Saudi Arabia, Iraq, Thailand, Malaysia, and Indonesia, consistently demonstrating superior diagnostic performance compared to the Alvarado score in these settings.

The 15 RIPASA Parameters

The RIPASA score evaluates 15 clinical parameters organized into five categories: demographics, symptoms, signs, investigations, and an additional criterion. Each parameter carries a specific point value reflecting its diagnostic weight.

Demographics (2 Parameters)

Parameter	Option	Points
Gender	Male	1.0
	Female	0.5
Age	≤ 40 years	1.0
	> 40 years	0.5

The demographic parameters reflect the known epidemiology of acute appendicitis. The condition has a higher incidence in males (male-to-female ratio of approximately 1.4:1), and peak incidence occurs between the ages of 10 and 30 years. Males receive a full point because the pretest probability of appendicitis is higher in this group when presenting with right iliac fossa pain. Similarly, patients aged 40 years or younger are scored higher because appendicitis is more prevalent in younger populations, while older patients are more likely to have alternative diagnoses such as diverticulitis, malignancy, or mesenteric ischemia.

Symptoms (5 Parameters)

Parameter	Option	Points
Right iliac fossa (RIF) pain	Present	0.5
	Absent	0
Migration of pain to RLQ	Present	0.5
	Absent	0
Anorexia	Present	1.0
	Absent	0
Nausea and vomiting	Present	1.0
	Absent	0
Duration of symptoms	< 48 hours	1.0
	≥ 48 hours	0.5

Right iliac fossa pain is the cardinal symptom of appendicitis, present in the vast majority of cases. However, it receives only 0.5 points because it is a nonspecific finding that can accompany numerous other conditions (mesenteric lymphadenitis, ovarian pathology, Crohn disease, ureterolithiasis). Its low weighting reflects high sensitivity but low specificity.

Migration of pain from the periumbilical region to the right lower quadrant is a hallmark of appendicitis pathophysiology. The visceral, poorly localized periumbilical pain reflects early appendiceal distension and irritation of visceral afferents, while the subsequent shift to the right iliac fossa indicates parietal peritoneal inflammation as the appendiceal inflammation progresses. This classic sequence was first described by Murphy and is often referred to as the "Murphy sequence." Its presence is moderately specific for appendicitis.

Anorexia (loss of appetite) is considered a near-universal symptom of appendicitis, present in 75-90% of confirmed cases. Some surgical teaching holds that if a patient with suspected appendicitis expresses hunger, the diagnosis should be reconsidered. The RIPASA score assigns anorexia a full 1.0 point, reflecting its strong association with the condition.

Nausea and vomiting occur in approximately 60-75% of patients with appendicitis. They typically follow the onset of abdominal pain (rather than preceding it, which would suggest a primary gastrointestinal process like gastroenteritis). The temporal relationship between pain onset and vomiting is clinically important, though the RIPASA score does not explicitly assess this sequence.

Duration of symptoms less than 48 hours receives a full 1.0 point because early appendicitis is more likely to present acutely with short symptom duration. Patients presenting after 48 hours may have developed complications (perforation, abscess) or may have an alternative diagnosis mimicking appendicitis. However, prolonged duration still receives 0.5 points because delayed presentation of genuine appendicitis does occur.

Signs (5 Parameters)

Parameter	Option	Points
RIF tenderness	Present	1.0
	Absent	0
RIF guarding	Present	2.0
	Absent	0
Rebound tenderness	Present	1.0
	Absent	0
Rovsing's sign	Present	2.0
	Absent	0
Fever (> 37 °C / 98.6 °F)	Present	1.0
	Absent	0

Right iliac fossa tenderness is the most consistent physical finding in appendicitis, present in over 95% of cases. McBurney's point, located one-third of the distance from the anterior superior iliac spine to the umbilicus, is the classic location of maximal tenderness. The finding receives 1.0 point, reflecting its high sensitivity.

RIF guarding is an involuntary contraction of the abdominal wall muscles overlying the inflamed appendix. It indicates peritoneal irritation and suggests a more advanced stage of appendiceal inflammation or early localized peritonitis. Guarding receives the highest individual point value of 2.0 points, reflecting its strong specificity for a significant intra-abdominal inflammatory process.

Rebound tenderness (Blumberg sign) refers to pain that is worsened upon sudden release of pressure during abdominal palpation. Like guarding, it indicates parietal peritoneal inflammation. While its sensitivity for appendicitis is moderate (approximately 60-70%), its presence raises clinical concern for peritonitis and increases diagnostic confidence.

Rovsing's sign is pain in the right iliac fossa elicited by palpation of the left iliac fossa. The mechanism involves transmission of peritoneal stretch from the left side to the inflamed peritoneum in the right iliac fossa. Rovsing's sign is relatively specific for appendicitis and receives 2.0 points, the joint-highest weighting in the score along with guarding. Its presence in a patient with right-sided abdominal pain strongly supports the diagnosis.

Fever greater than 37 °C (98.6 °F) is common in appendicitis but nonspecific. Low-grade fever (37.2-38.5 °C) is typical of uncomplicated appendicitis, while higher temperatures (>38.5 °C) may suggest perforation, abscess formation, or an alternative diagnosis. The threshold of 37 °C in the RIPASA score is intentionally low to capture early, mild febrile responses.

Investigations (2 Parameters)

Parameter	Option	Points
Raised white cell count (WCC)	Present	1.0
	Absent	0
Negative urinalysis	Yes	1.0
	No	0

Raised white cell count (leukocytosis, generally defined as WCC > 10,000/μL) is present in approximately 80-85% of patients with acute appendicitis. The degree of leukocytosis may correlate with disease severity: mild elevation is common in uncomplicated appendicitis, while marked leukocytosis (WCC > 18,000-20,000/μL) suggests complicated disease (perforation, gangrenous appendicitis, or abscess). A neutrophilic left shift further increases the diagnostic utility. However, a normal WCC does not exclude appendicitis, as up to 15-20% of patients with surgically confirmed appendicitis have a normal leukocyte count.

Negative urinalysis receives 1.0 point because a normal urinalysis helps differentiate appendicitis from urological conditions that can mimic it, particularly right ureteric colic, urinary tract infection, and pyelonephritis. A urinalysis showing significant pyuria, bacteriuria, or hematuria redirects the clinical suspicion toward a urinary tract pathology. However, it is important to note that mild urinary abnormalities (trace leukocytes, few red blood cells) can occur in appendicitis if the inflamed appendix lies in close proximity to the ureter or bladder, so minor abnormalities should be interpreted with caution.

Additional Criterion (1 Parameter)

Parameter	Option	Points
Foreign NRIC	Yes	1.0
	No	0

The Foreign National Registration Identity Card (NRIC) criterion is unique to the RIPASA score and reflects the specific population studied. In the original Brunei cohort, foreign workers tended to present later in the course of illness and had a higher proportion of confirmed appendicitis at the time of presentation, likely due to delayed healthcare access, language barriers, and hesitancy to seek medical attention. This additional point functions as a proxy for delayed presentation in migrant or foreign worker populations. In settings outside of Brunei, this parameter is often interpreted more broadly as representing patients who may have barriers to healthcare access or delayed presentation patterns.

Score Interpretation and Risk Stratification

The total RIPASA score ranges from 1.5 (minimum, based on demographic baselines) to 16.0 (maximum, all parameters positive). The score is stratified into four risk categories:

Score Range	Category	Clinical Interpretation
< 5.0	Unlikely	Appendicitis is unlikely. Consider alternative diagnoses. Discharge with appropriate follow-up and return precautions.
5.0 - 7.0	Low Probability	Low probability of appendicitis. Observe for 1-2 hours and repeat the score. Consider additional imaging (CT or ultrasound) if clinical suspicion persists.
7.5 - 11.5	High Probability	High probability of acute appendicitis. Refer for surgical consultation. Confirmatory imaging may be obtained per institutional protocol.
> 12.0	Definite Appendicitis	Strongly suggestive of appendicitis. Prompt surgical referral and appendectomy planning recommended.

The diagnostic cut-off of 7.5 was selected to optimize the balance between sensitivity and specificity. At this threshold, the RIPASA score captures the vast majority of true appendicitis cases while maintaining an acceptable rate of false positives. In the original validation study, the sensitivity at this cut-off was 98.0% and the specificity was 81.3%.

Diagnostic Performance

The RIPASA score has been evaluated in numerous validation studies across diverse populations. The following summarizes the key performance metrics:

Original Derivation Study (Chong et al., 2010)

• Sensitivity: 98.0%
• Specificity: 81.3%
• Positive Predictive Value: 85.3%
• Negative Predictive Value: 97.4%
• Diagnostic Accuracy: 91.8%
• Negative Appendectomy Rate: 14.7% (compared to 22.4% with the Alvarado score)

Comparison with the Alvarado Score

In the same derivation cohort, the Alvarado score at a cut-off of 7 achieved a sensitivity of only 68.3%, a specificity of 87.9%, a PPV of 86.3%, an NPV of 71.4%, and a diagnostic accuracy of 86.5%. The RIPASA score's key advantage was its dramatically higher sensitivity (98.0% vs. 68.3%), meaning it missed far fewer cases of true appendicitis.

Multiple subsequent studies have confirmed this pattern. A meta-analysis of comparative studies in Asian and Middle Eastern populations demonstrated that the RIPASA score consistently outperforms the Alvarado score in sensitivity (pooled sensitivity 94-98% vs. 58-75%) while maintaining comparable or slightly lower specificity (78-83% vs. 73-88%). In clinical practice, this means the RIPASA score is better at "ruling in" appendicitis and reduces the rate of missed diagnoses.

Pathophysiology of Acute Appendicitis

Understanding the pathophysiology of appendicitis provides context for why the RIPASA parameters are diagnostically meaningful. The progression of appendicitis typically follows a well-characterized sequence:

Luminal Obstruction

Appendicitis most commonly begins with obstruction of the appendiceal lumen. The most frequent cause is a fecalith (also called an appendicolith), a hardened mass of fecal material that forms within the appendix. Other causes of obstruction include lymphoid hyperplasia (particularly in children and young adults, often following viral infections), foreign bodies, parasitic infections (e.g., Enterobius vermicularis), and, rarely, appendiceal tumors (carcinoid, adenocarcinoma, mucinous neoplasms).

Mucosal Secretion and Distension

Following obstruction, the appendiceal mucosa continues to secrete mucus and fluid into the obstructed lumen, leading to progressive intraluminal pressure elevation. As pressure rises, venous outflow is impaired, leading to mucosal ischemia, loss of epithelial integrity, and translocation of intraluminal bacteria into the appendiceal wall. This stage corresponds to early appendicitis, where the patient experiences visceral, poorly localized periumbilical pain.

Transmural Inflammation and Peritoneal Irritation

As the inflammatory process extends through the full thickness of the appendiceal wall, it reaches the serosa and the overlying parietal peritoneum. This produces the characteristic somatic, well-localized right iliac fossa pain. At this stage, physical examination findings such as RIF tenderness, guarding, rebound tenderness, and Rovsing's sign become apparent. The RIPASA sign parameters capture this progression.

Perforation and Complications

If untreated, continued ischemia leads to gangrene and eventual perforation, typically occurring 36 to 72 hours after symptom onset. Perforation can result in localized abscess formation (if the omentum and adjacent bowel wall off the perforation) or diffuse peritonitis (if contamination spreads freely into the peritoneal cavity). Perforation rates increase with diagnostic delay, emphasizing the importance of timely clinical assessment using tools such as the RIPASA score.

Epidemiology of Acute Appendicitis

Acute appendicitis is the most common abdominal surgical emergency globally. Key epidemiological features include:

• Lifetime risk: 7-8% overall (8.6% in males, 6.7% in females).
• Peak incidence: Between ages 10 and 30, with the highest rates in the second and third decades of life.
• Sex distribution: Males have a slightly higher incidence (male-to-female ratio approximately 1.2-1.4:1), although this difference narrows with age.
• Geographic variation: Higher incidence in industrialized countries (10-15 per 100,000 population per year) compared to developing nations, possibly related to dietary fiber content and bowel transit time.
• Seasonal patterns: Some studies report a slight summer predominance, possibly related to increased rates of gastrointestinal infections causing lymphoid hyperplasia.
• Perforation rates: Overall perforation rates at presentation are 20-30%, but they rise sharply in children under 5 (approaching 80-100%) and adults over 65 (50-70%), reflecting diagnostic difficulty in these age groups.

Differential Diagnosis of Right Iliac Fossa Pain

The RIPASA score must be interpreted in the context of a broad differential diagnosis. Right iliac fossa pain can result from numerous conditions, and a low RIPASA score should prompt consideration of alternatives:

Gastrointestinal

• Mesenteric lymphadenitis: Common in children and young adults, often following upper respiratory or gastrointestinal viral infection. Pain is typically more diffuse and less severe.
• Meckel's diverticulitis: Inflammation of a Meckel diverticulum can closely mimic appendicitis. It is indistinguishable on clinical grounds and is typically diagnosed intraoperatively.
• Crohn disease: Terminal ileitis from Crohn disease can present identically to appendicitis. A history of chronic diarrhea, weight loss, or prior episodes may provide clues.
• Cecal diverticulitis: More common in Asian populations, right-sided diverticulitis of the cecum produces localized RIF pain indistinguishable from appendicitis on examination.
• Typhilitis (neutropenic colitis): Inflammation of the cecum in immunocompromised or neutropenic patients.

Gynecological (in female patients)

• Ruptured ovarian cyst: Sudden onset of unilateral pelvic pain, often mid-cycle.
• Ovarian torsion: Acute, severe, colicky pelvic pain with nausea and vomiting.
• Ectopic pregnancy: Must be excluded in all women of reproductive age with acute abdominal pain. A urine or serum beta-hCG is mandatory.
• Pelvic inflammatory disease (PID): Bilateral lower abdominal pain with vaginal discharge, cervical motion tenderness, and fever.
• Endometriosis: Cyclical pain pattern, often with history of dysmenorrhea.

Urological

• Right ureteric colic: Severe, colicky flank-to-groin pain with hematuria. A positive urinalysis (hematuria) would reduce the RIPASA score.
• Urinary tract infection / pyelonephritis: Dysuria, frequency, and pyuria on urinalysis. Right-sided pyelonephritis can cause RIF pain if the lower pole of the kidney is involved.

Other

• Right-sided inguinal hernia (incarcerated): Examine the inguinal regions in all patients with lower abdominal pain.
• Psoas abscess: Deep-seated pain with hip flexion deformity and signs of systemic sepsis.
• Epiploic appendagitis: Self-limiting inflammation of fatty appendages on the colonic surface; diagnosed on CT.

Role of Imaging in Conjunction with the RIPASA Score

The RIPASA score was designed to function as a clinical decision-making tool that could reduce reliance on imaging, particularly in resource-limited settings. However, imaging studies remain important adjuncts:

Ultrasound

Abdominal ultrasound is the first-line imaging modality in many settings, particularly for children, pregnant women, and young women of reproductive age. A non-compressible, blind-ending tubular structure in the right iliac fossa with a diameter exceeding 6 mm is diagnostic. Ultrasound sensitivity for appendicitis ranges from 75-90% depending on operator experience and patient body habitus, but specificity is high (85-98%). In patients with a RIPASA score in the "low probability" range (5-7), ultrasound can help differentiate appendicitis from gynecological or urological pathology.

CT Abdomen/Pelvis

Computed tomography is the most accurate imaging modality for appendicitis, with sensitivity and specificity both exceeding 95% in most studies. CT findings include appendiceal diameter > 6 mm, periappendiceal fat stranding, appendiceal wall enhancement, appendicolith, and secondary signs such as free fluid or cecal wall thickening. In patients with intermediate RIPASA scores or atypical presentations, CT provides definitive diagnostic information. However, concerns about radiation exposure and cost limit its routine use in all patients with suspected appendicitis.

MRI

Magnetic resonance imaging is increasingly used for suspected appendicitis in pregnant patients, where both ultrasound and CT have limitations (limited acoustic windows in the third trimester and ionizing radiation concerns, respectively). MRI has sensitivity and specificity comparable to CT and avoids radiation exposure.

RIPASA Score in Special Populations

Pediatric Patients

Appendicitis in children, particularly those under 5 years of age, poses significant diagnostic challenges. Young children cannot reliably describe their symptoms, and the classic presentation is often absent. The RIPASA score was not specifically validated in pediatric populations, and its demographic parameters (age threshold of 40 years) limit its utility in children. The Pediatric Appendicitis Score (PAS) or the Alvarado score adapted for children are generally preferred in this age group.

Elderly Patients

Elderly patients frequently present with atypical symptoms, blunted febrile responses, and delayed onset of leukocytosis. These patients also have a higher incidence of complicated appendicitis (perforation rates 50-70%) due to delayed diagnosis. While the RIPASA score can be applied in older adults, clinicians should maintain a lower threshold for advanced imaging (CT) given the atypical presentations and broader differential diagnosis in this population.

Pregnant Patients

Appendicitis is the most common non-obstetric surgical emergency during pregnancy, occurring in approximately 1 in 500-1,000 pregnancies. Diagnosis is challenging because the gravid uterus displaces the appendix superiorly and laterally, altering the location of pain and tenderness. Leukocytosis is physiological in pregnancy, reducing the diagnostic utility of WCC. Nausea and vomiting are common in early pregnancy, confounding symptom assessment. The RIPASA score has not been specifically validated in pregnant patients, and imaging with ultrasound or MRI (rather than CT) is preferred in this population.

Obese Patients

Obesity complicates both clinical assessment and imaging interpretation. Physical examination findings such as tenderness, guarding, and rebound tenderness may be attenuated by thick abdominal wall adipose tissue. Ultrasound sensitivity is reduced in obese patients due to limited acoustic penetration. CT remains accurate but may require higher radiation doses. The RIPASA score can be applied normally, but clinicians should be aware that clinical signs may be less reliable.

Comparison with Other Appendicitis Scoring Systems

Several clinical scoring systems exist for the diagnosis of acute appendicitis. Understanding their relative strengths and weaknesses contextualizes the role of the RIPASA score:

Alvarado Score (MANTRELS)

The Alvarado score, developed in 1986, uses 8 parameters (Migration of pain, Anorexia, Nausea/vomiting, Tenderness in RLQ, Rebound tenderness, Elevated temperature, Leukocytosis, Shift to left of neutrophils) totaling 10 points. It is the most widely studied appendicitis scoring system globally. At a cut-off of 7, its sensitivity ranges from 58-88% and specificity from 73-88%, depending on the population studied. Its main limitation in Asian and Middle Eastern populations is reduced sensitivity, which the RIPASA score was designed to address.

Modified Alvarado Score

The Modified Alvarado Score omits the "shift to left" criterion (which requires a differential white cell count that may not be readily available), reducing the total to 9 points. This simplification makes it more practical in resource-limited settings but slightly reduces diagnostic performance.

Appendicitis Inflammatory Response (AIR) Score

The AIR score, developed in Sweden (2008), incorporates C-reactive protein (CRP) levels in addition to clinical and laboratory parameters. It uses a three-tier classification (low, intermediate, high probability) and has demonstrated good performance in Western populations. The inclusion of CRP adds specificity but requires a laboratory result that may not be immediately available in all emergency departments.

Adult Appendicitis Score (AAS)

The AAS, published in 2014, incorporates WCC, CRP, and clinical parameters into a score that classifies patients into three risk groups with corresponding management pathways (discharge, imaging, surgery). It has shown good calibration and discrimination in Finnish and international validation studies.

Scoring System	Year	Parameters	Max Score	Cut-off	Target Population
RIPASA	2010	15	16	7.5	Asian / Middle Eastern
Alvarado	1986	8	10	7	Western / General
Modified Alvarado	1994	7	9	7	Western / General
AIR Score	2008	8	12	5 / 9	Western / General
AAS	2014	8	Continuous	11 / 16	Western / General

Negative Appendectomy Rate and Clinical Impact

A key metric in evaluating any appendicitis diagnostic tool is its impact on the negative appendectomy rate, the proportion of patients who undergo appendectomy only to have a histologically normal appendix. Historically, negative appendectomy rates ranged from 15-30%, with higher rates in women of reproductive age where gynecological pathology frequently mimics appendicitis.

In the original RIPASA validation study, the negative appendectomy rate using the RIPASA score at a cut-off of 7.5 was 14.7%, compared to 22.4% using the Alvarado score at a cut-off of 7. Subsequent validation studies have reported negative appendectomy rates of 10-18% when the RIPASA score is incorporated into clinical decision-making. This reduction translates to fewer unnecessary surgeries, reduced surgical complications, shorter hospital stays, and lower healthcare costs.

Conversely, the RIPASA score's high sensitivity means that fewer cases of true appendicitis are missed, reducing the rate of delayed diagnosis and the associated risk of perforation, peritonitis, and prolonged hospitalization.

Practical Application: Step-by-Step Scoring

Applying the RIPASA score at the bedside is straightforward and can be completed within minutes during the initial clinical assessment:

1. Record demographics: Assign 1.0 or 0.5 points each for gender and age.
2. Assess symptoms: Ask about right iliac fossa pain, migration of pain, anorexia, nausea/vomiting, and duration of symptoms. Assign points for each.
3. Perform physical examination: Evaluate for RIF tenderness, guarding, rebound tenderness, Rovsing's sign, and fever. Assign points.
4. Review investigations: Check the full blood count for leukocytosis and the urinalysis for abnormalities. Assign points.
5. Assess the additional criterion: Determine if the foreign NRIC criterion applies. Assign points.
6. Sum the total score: Add all individual parameter scores.
7. Interpret the result: Classify as unlikely (<5), low probability (5-7), high probability (7.5-11.5), or definite (>12).
8. Decide next steps: For unlikely and low probability scores, consider observation, repeat scoring in 1-2 hours, or alternative imaging. For high probability and definite scores, refer for surgical consultation.

Strengths of the RIPASA Score

• High sensitivity: At 98%, the RIPASA score misses very few cases of true appendicitis, making it an excellent screening tool.
• Simple and rapid: All 15 parameters can be assessed during routine clinical evaluation without specialized equipment or advanced investigations.
• Validated in Asian and Middle Eastern populations: The RIPASA score addresses a recognized gap in diagnostic performance left by the Alvarado score in these demographics.
• Reduces negative appendectomy rates: Multiple studies demonstrate a lower rate of unnecessary appendectomies when the RIPASA score guides clinical decision-making.
• Four-tier stratification: The graded risk classification (unlikely, low, high, definite) allows for nuanced clinical decisions, including observation and repeat scoring for intermediate cases.
• Includes urinalysis: Unlike the Alvarado score, the RIPASA score incorporates urinalysis, helping to exclude urological mimics of appendicitis.
• Accounts for symptom duration: The inclusion of symptom duration recognizes that the timing of presentation influences diagnostic probability.

Limitations of the RIPASA Score

• Population specificity: The RIPASA score was derived and primarily validated in Asian and Middle Eastern populations. Its performance in Western, African, or Latin American populations has been less extensively studied, and some studies in Western cohorts have shown lower sensitivity than in the original population.
• Foreign NRIC criterion: The additional criterion for foreign national identity card is specific to the Brunei healthcare context and may not be directly applicable in other countries. This parameter is often omitted or reinterpreted in external validation studies, which can alter scoring thresholds.
• Subjective parameters: Several parameters (guarding, rebound tenderness, Rovsing's sign) depend on examiner skill and interpretation, introducing inter-observer variability.
• Does not incorporate imaging: The RIPASA score is purely a clinical/laboratory tool. It does not integrate findings from ultrasound, CT, or MRI, which are increasingly used in modern emergency department pathways.
• Does not include C-reactive protein (CRP): Unlike the AIR score and AAS, the RIPASA score does not include CRP, which has been shown to improve diagnostic accuracy for appendicitis, particularly in distinguishing complicated from uncomplicated cases.
• Limited pediatric validation: The score has not been extensively studied in children, limiting its applicability in pediatric emergency settings.
• Binary parameter assessment: Most parameters are assessed as present or absent, without grading their severity. For example, mild RIF tenderness and severe, exquisite tenderness both receive the same 1.0 point.
• Does not predict complications: The RIPASA score diagnoses appendicitis but does not stratify the risk of perforation, abscess, or other complications. Separate clinical and imaging assessment is needed for surgical planning.

Clinical Pearls

• The RIPASA score is optimized for populations where the Alvarado score underperforms. In Western populations, the Alvarado, AIR, or AAS scores may provide comparable or superior diagnostic performance.
• A RIPASA score below 5 has a negative predictive value exceeding 97%, making it a powerful tool for safely ruling out appendicitis and avoiding unnecessary hospital admissions.
• For patients with scores in the low-probability range (5-7), serial reassessment after 1-2 hours of observation is recommended rather than immediate discharge. Repeat scoring can capture evolving clinical findings as appendiceal inflammation progresses.
• Rovsing's sign and RIF guarding carry the highest individual point values (2.0 each). Their presence alone shifts the score significantly toward a positive diagnosis.
• Always perform a urinalysis in the workup of right iliac fossa pain. A negative urinalysis adds 1.0 point to the RIPASA score and simultaneously helps exclude urological pathology.
• In women of reproductive age, obtain a serum or urine beta-hCG before applying the RIPASA score to exclude ectopic pregnancy, which the scoring system does not address.
• The RIPASA score does not replace clinical judgment. A patient with a score below the diagnostic threshold who appears clinically unwell should still receive further investigation. Conversely, a patient with a high score but an identified alternative diagnosis should not be committed to appendectomy based on the score alone.
• The symptom duration parameter distinguishes between early (<48 hours) and late (≥48 hours) presentations. Patients presenting after 48 hours who receive a score below the cut-off may still have complicated appendicitis (walled-off perforation, abscess) requiring imaging even if the acute score is not elevated.
• In resource-limited settings without access to CT, the RIPASA score provides a structured, evidence-based framework for clinical decision-making that can safely guide the management of most patients with suspected appendicitis.